BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Melaiu O, Lucarini V, Giovannoni R, Fruci D, Gemignani F. News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors. Semin Cancer Biol 2020:S1044-579X(20)30156-5. [PMID: 32659257 DOI: 10.1016/j.semcancer.2020.07.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Shi H, Li K, Ni Y, Liang X, Zhao X. Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy. Front Cell Dev Biol 2021;9:707198. [PMID: 34336860 DOI: 10.3389/fcell.2021.707198] [Reference Citation Analysis]
2 Palmisani F, Kovar H, Kager L, Amann G, Metzelder M, Bergmann M. Systematic review of the immunological landscape of Wilms tumors. Mol Ther Oncolytics 2021;22:454-67. [PMID: 34553032 DOI: 10.1016/j.omto.2021.06.016] [Reference Citation Analysis]
3 Han S, Zhu W, Yang W, Guan Q, Chen C, He Q, Zhong Z, Zhao R, Xiong H, Han H, Li Y, Sun Z, Hu X, Tian J. A Prognostic Signature Constructed by CTHRC1 and LRFN4 in Stomach Adenocarcinoma. Front Genet 2021;12:646818. [PMID: 34512711 DOI: 10.3389/fgene.2021.646818] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Xu L, Ling J, Su C, Su YW, Xu Y, Jiang Z. Emerging Roles on Immunological Effect of Indoleamine 2,3-Dioxygenase in Liver Injuries. Front Med (Lausanne) 2021;8:756435. [PMID: 34869457 DOI: 10.3389/fmed.2021.756435] [Reference Citation Analysis]
5 Lucarini V, Melaiu O, Tempora P, D'Amico S, Locatelli F, Fruci D. Dendritic Cells: Behind the Scenes of T-Cell Infiltration into the Tumor Microenvironment. Cancers (Basel) 2021;13:433. [PMID: 33498755 DOI: 10.3390/cancers13030433] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Mints M, Tirosh I. Nasopharyngeal carcinoma joins the single-cell party. Cancer Commun (Lond) 2020;40:453-5. [PMID: 32841535 DOI: 10.1002/cac2.12091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Zhou X, Ren T, Zan H, Hua C, Guo X. Novel Immune Checkpoints in Esophageal Cancer: From Biomarkers to Therapeutic Targets. Front Immunol 2022;13:864202. [DOI: 10.3389/fimmu.2022.864202] [Reference Citation Analysis]
8 Nelson A, Gebremeskel S, Lichty BD, Johnston B. Natural killer T cell immunotherapy combined with IL-15-expressing oncolytic virotherapy and PD-1 blockade mediates pancreatic tumor regression. J Immunother Cancer 2022;10:e003923. [PMID: 35246474 DOI: 10.1136/jitc-2021-003923] [Reference Citation Analysis]
9 Huang J, Liu D, Wang Y, Liu L, Li J, Yuan J, Jiang Z, Jiang Z, Hsiao WW, Liu H, Khan I, Xie Y, Wu J, Xie Y, Zhang Y, Fu Y, Liao J, Wang W, Lai H, Shi A, Cai J, Luo L, Li R, Yao X, Fan X, Wu Q, Liu Z, Yan P, Lu J, Yang M, Wang L, Cao Y, Wei H, Leung EL. Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy. Gut 2021:gutjnl-2020-321031. [PMID: 34006584 DOI: 10.1136/gutjnl-2020-321031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Wienke J, Dierselhuis MP, Tytgat GAM, Künkele A, Nierkens S, Molenaar JJ. The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology. Eur J Cancer 2021;144:123-50. [PMID: 33341446 DOI: 10.1016/j.ejca.2020.11.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
11 Nelson A, Lukacs JD, Johnston B. The Current Landscape of NKT Cell Immunotherapy and the Hills Ahead. Cancers (Basel) 2021;13:5174. [PMID: 34680322 DOI: 10.3390/cancers13205174] [Reference Citation Analysis]
12 Nigro O, Ferrari A, Casanova M, Orbach D, Leruste A, Gatz SA, Frappaz D, Massimino M. Controversies on the possible role of immune checkpoint inhibitors in pediatric cancers: balancing irAEs and efficacy. Tumori 2021;107:276-81. [PMID: 33877022 DOI: 10.1177/03008916211010214] [Reference Citation Analysis]
13 Che K, Han W, Li D, Cui S, Zhang M, Yang X, Niu H. Correlations between glycolysis with clinical traits and immune function in bladder urothelial carcinoma. Biosci Rep 2021;41:BSR20203982. [PMID: 33558879 DOI: 10.1042/BSR20203982] [Cited by in F6Publishing: 1] [Reference Citation Analysis]